Abstract
Nanotechnologies seem to have huge potential to bring benefits in areas as diverse as drug development, water decontamination, information and communication infrastructures, and the production of stronger, lighter and perfect nanomaterials. This potential attracts global investment from governments and private sectors in nanotechnologies with the hopes that R and commercial applications of nanomaterials, nanodevices, nanoparticles and nanodrugs will provide new impetus, after the ebb-tides of biotechnology and dotcom, to turn faltering economies around. The global governmental funding has been actively promoting industrial and academic cooperation to realize big prosperity from the nanotechnologies. This article summarizes historic trends and status of global governmental supports for nanotechnologies.
Keywords: nanotechnology, governmental nanotechnology funding
Current Nanoscience
Title: Global Governmental Investment in Nanotechnologies
Volume: 1 Issue: 3
Author(s): Lee Jia
Affiliation:
Keywords: nanotechnology, governmental nanotechnology funding
Abstract: Nanotechnologies seem to have huge potential to bring benefits in areas as diverse as drug development, water decontamination, information and communication infrastructures, and the production of stronger, lighter and perfect nanomaterials. This potential attracts global investment from governments and private sectors in nanotechnologies with the hopes that R and commercial applications of nanomaterials, nanodevices, nanoparticles and nanodrugs will provide new impetus, after the ebb-tides of biotechnology and dotcom, to turn faltering economies around. The global governmental funding has been actively promoting industrial and academic cooperation to realize big prosperity from the nanotechnologies. This article summarizes historic trends and status of global governmental supports for nanotechnologies.
Export Options
About this article
Cite this article as:
Jia Lee, Global Governmental Investment in Nanotechnologies, Current Nanoscience 2005; 1 (3) . https://dx.doi.org/10.2174/157341305774642957
DOI https://dx.doi.org/10.2174/157341305774642957 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Thinking Outside the ‘Block’: Alternative Polymer Compositions for Micellar Drug Delivery
Current Topics in Medicinal Chemistry Novel Small-Molecule Inhibitors of Arylamine N-Acetyltransferases: Drug Discovery by High Throughput Screening
Combinatorial Chemistry & High Throughput Screening Therapeutic Molecules for Fumigating Inflammatory Tumor Environment
Current Signal Transduction Therapy Genetic Susceptibility to Risk for Bladder Cancer in Individuals Working in High Risk Occupations
Current Pharmacogenomics Clinicopathological and Imaging Features Predictive of Clinical Outcome in Metaplastic Breast Cancer
Current Medical Imaging Ligand Docking and Structure-based Virtual Screening in Drug Discovery
Current Topics in Medicinal Chemistry Physiologic Versus Diabetogenic Effects of Interleukin-1: A Question of Weight
Current Pharmaceutical Design Role of Transmembrane Domain/Transmembrane Domain Interfaces of PGlycoprotein (ABCB1) in Solute Transport. Convergent Information from Photoaffinity Labeling, Site Directed Mutagenesis and in Silico Importance Prediction
Current Medicinal Chemistry The Exploitation of Toll-like Receptor 3 Signaling in Cancer Therapy
Current Pharmaceutical Design T-type Calcium Channels in Health and Disease
Current Medicinal Chemistry Natural Product-Inspired Synthesis of Thiazolidine and Thiazolidinone Compounds and their Anticancer Activities
Current Pharmaceutical Design Stimuli-responsive Carriers for Controlled Intracellular Drug Release
Current Medicinal Chemistry Biodistribution and Pharmacokinetics of I-131 Labelled 4- Iodophenylacetic Acid
Current Radiopharmaceuticals Regulation of the DNA Damage Response to DSBs by Post-Translational Modifications
Current Genomics Genetic Instability Influences Drug Response in Cancer Cells
Current Drug Targets Nanoparticle-Based Therapy in Genomics
Current Drug Metabolism Current and Future Prospective of a Versatile Moiety: Imidazole
Current Drug Targets Evaluation of Dendrimer Safety and Efficacy through Cell Line Studies
Current Drug Targets Biologics: An Update and Challenge of Their Pharmacokinetics
Current Drug Metabolism The Role of Vitamin D in Dyslipidemia and Cardiovascular Disease
Current Pharmaceutical Design